Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Equity (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Return on Equity for 3 consecutive years, with 1.33% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 71.0% to 1.33% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.33% through Dec 2025, down 71.0% year-over-year, with the annual reading at 1.42% for FY2025, 23.0% down from the prior year.
  • Return on Equity hit 1.33% in Q4 2025 for Mangoceuticals, down from 1.13% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 98.19% in Q1 2024 to a low of 8.65% in Q4 2023.
  • Historically, Return on Equity has averaged 9.22% across 3 years, with a median of 0.72% in 2025.
  • Biggest five-year swings in Return on Equity: surged 802bps in 2024 and later crashed -9884bps in 2025.
  • Year by year, Return on Equity stood at 8.65% in 2023, then skyrocketed by 93bps to 0.63% in 2024, then plummeted by -113bps to 1.33% in 2025.
  • Business Quant data shows Return on Equity for MGRX at 1.33% in Q4 2025, 1.13% in Q3 2025, and 0.72% in Q2 2025.